How to Reduce Unnecessary Antibiotic Use in Respiratory Infections
On the occasion of European Antibiotic Awareness Day, observed on November 18, the Institut de Recerca Sant Pau (IR Sant Pau) highlights its research aimed at reducing the unnecessary use of these medications in children and adults with respiratory infections.
Respiratory infections are among the most common reasons for medical consultations during the fall and winter. Although many are caused by viruses and do not require antibiotics, deciding when to prescribe them remains a challenge in clinical practice. Clinical trials involving researchers from IR Sant Pau have shown that delaying antibiotic prescriptions for certain respiratory infections can considerably reduce antibiotic consumption, without significant differences in patient outcomes. This strategy, known as delayed prescribing, allows patients to have a prescription and use it only if certain conditions are met.
Antibiotic resistance is already a major public health concern. According to estimates from the European Centre for Disease Prevention and Control (ECDC), based on 2020 data, more than 35,000 people die each year in the European Union and the European Economic Area as a result of infections caused by resistant bacteria. Unnecessary antibiotic use for respiratory infections contributes to the emergence and spread of resistance, which can make future infections more difficult to treat.
Delayed Prescribing to Avoid Unnecessary Treatments
Delayed antibiotic prescribing allows healthcare professionals to provide a prescription while instructing patients to start treatment only if their symptoms develop in a particular way or certain previously established conditions are met. This approach aims to avoid immediate antibiotic use when it is not essential, while ensuring that patients receive clear instructions on how to respond as the infection progresses.
The team led by Dr. Pablo Alonso-Coello, head of the Clinical Epidemiology and Healthcare Services Research Group at IR Sant Pau, has studied the effectiveness of this strategy in both adults and children through two clinical trials. One of these studies, published in Pediatrics, one of the world's most influential pediatric journals, evaluated 436 children aged 2 to 14 years with uncomplicated respiratory infections, including pharyngitis, rhinosinusitis, acute bronchitis, and acute otitis media, treated at 39 primary care centers in Spain.
Participants were randomly assigned to three strategies: receiving an immediate antibiotic prescription, receiving a prescription to be used only if certain conditions were met, or initially receiving no antibiotic prescription. In the delayed prescribing group, healthcare professionals explained to families how to respond as the infection progressed, under what circumstances treatment should be started, and when they should seek further medical advice.
The differences in antibiotic consumption were particularly significant. While 96% of children who received an immediate prescription ultimately took antibiotics, this percentage fell to 25.3% among those who received a delayed prescription and to 12% among those who were initially not prescribed antibiotics. The study also found no statistically significant differences between strategies in terms of symptom duration or severity, complications, additional consultations, or family satisfaction. Furthermore, gastrointestinal adverse effects were more frequent among children who received an immediate prescription.
“Delayed prescribing is not simply about handing over a prescription and waiting. It is important to explain under what circumstances treatment should begin, how the infection may progress, and when further medical advice is needed. This information helps avoid unnecessary antibiotics while ensuring that families have a clear plan of action,” explains Dr. Gemma Mas, professor at the Sant Pau University School of Nursing, head of the Nursing Care Research Group, and first author of the publication.
The researchers subsequently analyzed the cost-effectiveness of the different strategies in a study published in 2023 in BMC Pediatrics, using data from the pediatric trial. Delayed prescribing proved to be the most cost-effective option among those evaluated, considering the costs associated with antimicrobial resistance. Its average cost was €100.90 per patient, compared with €109.68 for immediate prescribing, with very similar health outcomes. The group that initially received no antibiotic prescription had a slightly lower cost of €97.48, although its effectiveness was also somewhat lower.
The research has also been conducted in adults. A trial published in 2016 in JAMA Internal Medicine, involving 398 patients treated at 23 primary care centers, showed that antibiotic use decreased from 91% with immediate prescribing to between 23% and 33% with the two delayed prescribing approaches evaluated. Although the latter were associated with a slightly longer duration of symptoms, the differences were considered clinically small.
The same research group conducted a qualitative study published in 2023 in BMC Primary Care to explore healthcare professionals' perceptions and attitudes toward antibiotics and delayed prescribing for respiratory infections. Primary care consultations for acute respiratory infections in adults were associated with low levels of health literacy, while inappropriate antibiotic use was linked to defensive medical practice. Healthcare professionals used delayed prescribing when there was uncertainty about the cause of the infection, considering the patient's profile and the context in which the consultation took place.
The findings of these studies have also helped inform healthcare policies. The clinical trials involving IR Sant Pau, as well as the qualitative study on healthcare professionals' perceptions, are among the studies included in a report published in 2025 by the Spanish Network of Agencies for Health Technology Assessment and National Health System Services (RedETS). The report, prepared at the request of Spain's National Plan Against Antibiotic Resistance (PRAN), draws on a systematic review of 12 clinical trials involving 3,750 patients and concludes that delayed prescribing significantly reduces antibiotic consumption without relevant differences in clinical outcomes compared with immediate prescribing.
This evidence is now being directly applied to public health policies. Spain's Ministry of Health, through the Spanish Agency of Medicines and Medical Devices (AEMPS), and the autonomous communities are working to expand delayed prescribing throughout the healthcare system as part of the PRAN initiatives. In September 2026, a working group was established to assess the extent to which this strategy has been implemented and promote its use where it has not yet been integrated. The initiative also aims to improve healthcare professionals' training and the information provided to patients.
Improving Communication With Families to Support Shared Decision-Making
More recently, researchers have expanded their work to focus on communication between healthcare professionals and families, an especially important aspect of caring for children with respiratory infections. In addition to determining when treatment is indicated, it is essential that families understand what is happening to their child, how long symptoms may last, and when they should seek further medical advice.
“The decision to prescribe an antibiotic does not depend solely on clinical evidence. It is also influenced by how we explain that decision to patients and how we address their questions and expectations. That is why healthcare professionals need tools to help them navigate these conversations,” says Dr. Ignasi Boribar.
To explore this area further, researchers analyzed the findings of 33 scientific reviews on educational interventions and factors influencing antibiotic prescribing in pediatric primary care. The study, published in 2025 in BMC Pediatrics, identified the importance of combining strategies aimed at healthcare professionals and families, tailored to their needs and the healthcare setting, to promote more appropriate use of these medications.
Based on this evidence, the OptimAP project was developed, combining two complementary interventions: a digital application for families and a communication skills training program for healthcare professionals. The application provides accessible information on the typical course of respiratory infections, the role of antibiotics, and warning signs that require further medical assessment, helping families understand the illness and participate in decisions about its management.
The training program, meanwhile, provides healthcare professionals with tools to explore families' concerns and expectations, explain the benefits and potential adverse effects of antibiotics, and agree on a management plan tailored to each case. Both interventions aim to support shared decision-making based on scientific evidence and promote appropriate antibiotic use in pediatric primary care.
The training program, whose development was described in a study published in 2025 in BMC Primary Care, is designed for pediatricians, pediatric nursing professionals, and community pharmacists. It consists of four modules, 19 topics, and 28 videos combining theoretical content, clinical cases, and practical examples of common conversations during medical consultations. The course is accredited for 25 hours of continuing education by the Catalan Council for Continuing Education of Healthcare Professionals. In an initial evaluation involving 16 professionals, participants rated the content positively and considered it useful for improving communication with families. The videos received an average score of 4.81 out of 5, and 93% of participants expressed interest in completing the course. These findings provide information about the tool's acceptability, although they do not yet establish its effectiveness in reducing antibiotic prescribing in clinical practice.
A Clinical Trial to Evaluate New Prescribing Tools
The team has completed a multicenter clinical trial with a factorial design, involving healthcare centers from several Spanish autonomous communities, to evaluate the interventions developed as part of the OptimAP project, both individually and in combination. The study was designed to determine the extent to which the application for families and the training program for healthcare professionals can help improve decisions about antibiotic prescribing for respiratory infections in children.
The trial results have not yet been published, and the researchers are continuing to analyze data from the evaluation of the implementation process. This analysis will provide a more profound understanding of how the interventions were carried out and which factors may facilitate or hinder their integration into clinical practice.
“Prudent antibiotic use depends both on clinical decisions and on the information patients receive. The studies conducted at IR Sant Pau provide evidence on how to avoid unnecessary prescriptions and explore new ways to support these decisions in primary care consultations,” concludes Dr. Pablo Alonso.
References:
- Mas-Dalmau G, Villanueva López C, Gorrotxategi Gorrotxategi P, Argüelles Prendes E, Espinazo Ramos O, Valls Duran T, Gonzalo Alonso ME, Cortés Viana MP, Menéndez Bada T, Vázquez Fernández ME, Pérez Hernández AI, Muñoz Ortiz L, Little P, de la Poza Abad M, Alonso-Coello P, DAP PEDIATRICS GROUP*. Delayed antibiotic prescription for children with respiratory infections: A randomized trial. Pediatrics 2021;147:e20201323. https://doi.org/10.1542/peds.2020-1323.
- de la Poza Abad M, Mas Dalmau G, Moreno Bakedano M, González González AI, Canellas Criado Y, Hernández Anadón S, Rotaeche del Campo R, Torán Monserrat P, Negrete Palma A, Muñoz Ortiz L, Borrell Thió E, Llor C, Little P, Alonso-Coello P, Delayed Antibiotic Prescription (DAP) Group. Prescription strategies in acute uncomplicated respiratory infections: A randomized clinical trial: A randomized clinical trial. JAMA Intern Med 2016;176:21–9. https://doi.org/10.1001/jamainternmed.2015.7088.
- Mas-Dalmau G, Pérez-Lacasta MJ, Alonso-Coello P, Gorrotxategi-Gorrotxategi P, Argüelles-Prendes E, Espinazo-Ramos O, Valls-Duran T, Gonzalo-Alonso ME, Cortés-Viana MP, Menéndez-Bada T, Vázquez-Fernández ME, Pérez-Hernández AI, Muñoz-Ortiz L, Villanueva-López C, Little P, de la Poza-Abad M, Carles-Lavila M, DAP Paediatrics Group. A trial-based cost-effectiveness analysis of antibiotic prescription strategies for non-complicated respiratory tract infections in children. BMC Pediatr 2023;23:497. https://doi.org/10.1186/s12887-023-04235-3.
- Mas-Dalmau G, Pequeño-Saco S, de la Poza-Abad M, Borrell-Thió E, Besa-Castellà M, Alsina-Casalduero M, Cuixart-Costa L, Liroz-Navarro M, Calderón-Gómez C, Martí J, Cruz-Gómez I, Alonso-Coello P. Perceptions and attitudes regarding delayed antibiotic prescription for respiratory tract infections: a qualitative study. BMC Prim Care. 2023 Oct 4;24(1):204. doi: 10.1186/s12875-023-02123-4.
- Elizondo-Alzola U, Rocha C, Leache L, León-García M, Saiz LC, Solà I, Montesinos-Guevara C, Meade A-G, Boldú A, Bolíbar I, Niño-de-Guzmán E, Alonso-Coello P. Educational interventions and contextual factors for optimising antibiotic prescription in paediatric uncomplicated acute respiratory tract infections in primary care: scoping review of reviews. BMC Pediatr 2025;25:421. https://doi.org/10.1186/s12887-025-05688-4.
- Arias-Alonso L, Barragán-Brun N, Elizondo-Alzola U, Boldu-Minguell A, Rocha-Calderón CA, Niño-de-Guzmán E, Santandreu FM, Quesada-Carrasco F, Ricci-Cabello I, Gorrotxategi-Gorrotxategi PJ, de la Poza-Abad M, Mas-Dalmau G, Gibert-Agulló A, González-Lama J, Alonso-Coello P. Development and assessment of an online communication skills course to optimise antibiotic prescribing for children in primary care. BMC Prim Care 2025;26:247. https://doi.org/10.1186/s12875-025-02919-6.